• Policy
• NA criticizes HIRA's low prior approval of specific drug
• by Lee, Tak-Sun Oct 30, 2023 05:29am

• Policy
• New dug price reeval standards will be set within the year
• by Lee, Jeong-Hwan Oct 27, 2023 05:33am

• Policy
• Galvusmet generics released in all dosage forms in KOR
• by Lee, Tak-Sun Oct 27, 2023 05:33am

• Policy
• Final PVA improvement plan to be prepared soon
• by Lee, Tak-Sun Oct 27, 2023 05:33am

• Policy
• Minister Cho will work to address shingles vaccine issue
• by Lee, Hye-Kyung Oct 26, 2023 06:06am

• Policy
• Prostate cancer tx Xtandi·Zytiga, 5% pt copayment applied
• by Lee, Tak-Sun Oct 26, 2023 06:06am

• Policy
• Will restrictions be eased for vaccine clinical trials?
• by Lee, Jeong-Hwan Oct 26, 2023 06:06am

• Policy
• Severe asthma txs Nucala and Cinqair are to be reimbursed
• by Lee, Jeong-Hwan Oct 24, 2023 05:22am

• Policy
• TZD combined DPP4i-SGLT2i complex
• by Lee, Tak-Sun Oct 24, 2023 05:21am

• Policy
• Announcement of dual pricing system
• by Lee, Jeong-Hwan Oct 20, 2023 05:32am